Zevra Therapeutics, Inc.
- ZVRA
- NASDAQ
- Biotechnology
- Rare Disease Therapeutics
- Ligand Activated Therapy
- Prodrug Technology
$9.94
Today −3.21%Quote Oct 16, 2026, 08:00 PM UTC
−16.05%over the last month
Max drawdown −16.0%From 1-month high −16.0%3 months −17.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$590.3M
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$25.75
+159.1% from here
Floor
$9.75
1.9% below price
Where the price sits
10 analysts
Analyst range, low to high
$20.00$35.00
- Price $9.94
- Resistance $10.44
- Consensus $25.75
The price is just above its floor. Analysts' average target sits about 159% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ZVRAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
61
Founded
2006